BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 13, 2009
View Archived Issues
Seattle Genetics Gets $118.2M for Antibody Conjugate, More
In the wake of a stock bump following a $2.4 billion acquisition offer for fellow antibody firm Medarex Inc., Seattle Genetics Inc. is boosting its cash position by $118.2 million through a public stock offering. (BioWorld Today)
Read More
Merrem Squeeze Helps Motivate AstraZeneca In Ceftaroline Deal
Read More
Late Gene Therapy Gain Chips Away at Critical Period Notion
Read More
Enzyme-Targeted Cancer Push Garners $17M for Constellation
Read More
Corrections & Clarifications
Read More
FDA: Experimental Therapy OK If Nothing Else Available
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More